PNC FINANCIAL SERVICES GROUP, INC. - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 102 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2016. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q1 2022$0350.0%0.00%
Q4 2021$0350.0%0.00%
Q3 2021$0
-100.0%
35
-14.6%
0.00%
Q2 2021$1,000
-99.5%
41
-99.4%
0.00%
Q1 2021$194,000
+1392.3%
6,906
+1264.8%
0.00%
Q4 2020$13,000
-31.6%
5060.0%0.00%
Q3 2020$19,000
-26.9%
5060.0%0.00%
Q2 2020$26,000
-58.1%
506
-74.4%
0.00%
Q1 2020$62,0001,976
+32833.3%
0.00%
Q4 2019$060.0%0.00%
Q3 2019$060.0%0.00%
Q2 2019$060.0%0.00%
Q1 2019$060.0%0.00%
Q4 2018$060.0%0.00%
Q3 2018$060.0%0.00%
Q2 2018$0
-100.0%
6
-91.5%
0.00%
Q2 2016$1,0000.0%71
-4.1%
0.00%
Q1 2016$1,000
-50.0%
74
+4.2%
0.00%
Q4 2015$2,0000.0%710.0%0.00%
Q3 2015$2,000
-66.7%
71
+2.9%
0.00%
Q2 2015$6,0000.0%69
-50.7%
0.00%
Q4 2014$6,000
+100.0%
1400.0%0.00%
Q3 2014$3,000
+50.0%
1400.0%0.00%
Q2 2014$2,0001400.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2016
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$20,735,0008.65%
Altium Capital Management LP 2,496,524$11,584,0003.88%
Deep Track Capital, LP 6,000,000$27,840,0001.78%
Paradigm Biocapital Advisors LP 1,157,246$5,370,0001.42%
Monaco Asset Management SAM 419,262$1,945,0000.77%
Rhenman & Partners Asset Management AB 981,582$4,555,0000.45%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$12,589,0000.39%
Bellevue Group AG 4,299,164$19,948,0000.23%
WASATCH ADVISORS LP 8,147,380$37,804,0000.19%
Telemetry Investments, L.L.C. 17,500$81,0000.13%
View complete list of ESPERION THERAPEUTICS INC NE shareholders